Selected research
Industry Research
AI for Clinical and Molecular Diagnostics Industry Research Report 2026
Market perspective
The global AI for Clinical and Molecular Diagnostics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI for Clinical and Molecular Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI for Clinical and Molecular Diagnostics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI for Clinical and Molecular Diagnostics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI for Clinical and Molecular Diagnostics include Roche, Fujifilm, Illumina, GE HealthCare, Philips, Medtronic, Microsoft, Siemens Healthineers and Intel, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI for Clinical and Molecular Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI for Clinical and Molecular Diagnostics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI for Clinical and Molecular Diagnostics Market by Company
Roche
Fujifilm
Illumina
GE HealthCare
Philips
Medtronic
Microsoft
Siemens Healthineers
Intel
Enlitic
NVIDIA
Qure AI
AI for Clinical and Molecular Diagnostics Segment by Type
Software
Services
Hardware
AI for Clinical and Molecular Diagnostics Segment by Application
Clinical Diagnostics
Molecular Diagnostics
AI for Clinical and Molecular Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI for Clinical and Molecular Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI for Clinical and Molecular Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI for Clinical and Molecular Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI for Clinical and Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Software
- Services
- Hardware
Applications
- Clinical Diagnostics
- Molecular Diagnostics
Companies covered
- Roche
- Fujifilm
- Illumina
- GE HealthCare
- Philips
- Medtronic
- Microsoft
- Siemens Healthineers
- Intel
- Enlitic
- NVIDIA
- Qure AI
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI for Clinical and Molecular Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Software
- 2.2.3 Services
- 2.2.4 Hardware
- 2.3 AI for Clinical and Molecular Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Diagnostics
- 2.3.3 Molecular Diagnostics
- 2.4 Assumptions and Limitations
3 AI for Clinical and Molecular Diagnostics Breakdown Data by Type
- 3.1 Global AI for Clinical and Molecular Diagnostics Historic Market Size by Type (2021-2026)
- 3.2 Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Type (2027-2032)
4 AI for Clinical and Molecular Diagnostics Breakdown Data by Application
- 4.1 Global AI for Clinical and Molecular Diagnostics Historic Market Size by Application (2021-2026)
- 4.2 Global AI for Clinical and Molecular Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI for Clinical and Molecular Diagnostics Market Perspective (2021-2032)
- 5.2 Global AI for Clinical and Molecular Diagnostics Growth Trends by Region
- 5.2.1 Global AI for Clinical and Molecular Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI for Clinical and Molecular Diagnostics Historic Market Size by Region (2021-2026)
- 5.2.3 AI for Clinical and Molecular Diagnostics Forecasted Market Size by Region (2027-2032)
- 5.3 AI for Clinical and Molecular Diagnostics Market Dynamics
- 5.3.1 AI for Clinical and Molecular Diagnostics Industry Trends
- 5.3.2 AI for Clinical and Molecular Diagnostics Market Drivers
- 5.3.3 AI for Clinical and Molecular Diagnostics Market Challenges
- 5.3.4 AI for Clinical and Molecular Diagnostics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI for Clinical and Molecular Diagnostics Players by Revenue
- 6.1.1 Global Top AI for Clinical and Molecular Diagnostics Players by Revenue (2021-2026)
- 6.1.2 Global AI for Clinical and Molecular Diagnostics Revenue Market Share by Players (2021-2026)
- 6.2 Global AI for Clinical and Molecular Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI for Clinical and Molecular Diagnostics Head Office and Area Served
- 6.4 Global AI for Clinical and Molecular Diagnostics Players, Product Type & Application
- 6.5 Global AI for Clinical and Molecular Diagnostics Manufacturers Established Date
- 6.6 Global AI for Clinical and Molecular Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI for Clinical and Molecular Diagnostics Market Size (2021-2032)
- 7.2 North America AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI for Clinical and Molecular Diagnostics Market Size by Country (2021-2026)
- 7.4 North America AI for Clinical and Molecular Diagnostics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI for Clinical and Molecular Diagnostics Market Size (2021-2032)
- 8.2 Europe AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI for Clinical and Molecular Diagnostics Market Size by Country (2021-2026)
- 8.4 Europe AI for Clinical and Molecular Diagnostics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size (2021-2032)
- 9.2 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI for Clinical and Molecular Diagnostics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI for Clinical and Molecular Diagnostics Market Size (2021-2032)
- 10.2 South America AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI for Clinical and Molecular Diagnostics Market Size by Country (2021-2026)
- 10.4 South America AI for Clinical and Molecular Diagnostics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size (2021-2032)
- 11.2 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI for Clinical and Molecular Diagnostics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.1.4 Roche AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 Fujifilm
- 12.2.1 Fujifilm Company Information
- 12.2.2 Fujifilm Business Overview
- 12.2.3 Fujifilm Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.2.4 Fujifilm AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.2.5 Fujifilm Recent Developments
- 12.3 Illumina
- 12.3.1 Illumina Company Information
- 12.3.2 Illumina Business Overview
- 12.3.3 Illumina Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.3.4 Illumina AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.3.5 Illumina Recent Developments
- 12.4 GE HealthCare
- 12.4.1 GE HealthCare Company Information
- 12.4.2 GE HealthCare Business Overview
- 12.4.3 GE HealthCare Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.4.4 GE HealthCare AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.4.5 GE HealthCare Recent Developments
- 12.5 Philips
- 12.5.1 Philips Company Information
- 12.5.2 Philips Business Overview
- 12.5.3 Philips Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.5.4 Philips AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.5.5 Philips Recent Developments
- 12.6 Medtronic
- 12.6.1 Medtronic Company Information
- 12.6.2 Medtronic Business Overview
- 12.6.3 Medtronic Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.6.4 Medtronic AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.6.5 Medtronic Recent Developments
- 12.7 Microsoft
- 12.7.1 Microsoft Company Information
- 12.7.2 Microsoft Business Overview
- 12.7.3 Microsoft Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.7.4 Microsoft AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.7.5 Microsoft Recent Developments
- 12.8 Siemens Healthineers
- 12.8.1 Siemens Healthineers Company Information
- 12.8.2 Siemens Healthineers Business Overview
- 12.8.3 Siemens Healthineers Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.8.4 Siemens Healthineers AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.8.5 Siemens Healthineers Recent Developments
- 12.9 Intel
- 12.9.1 Intel Company Information
- 12.9.2 Intel Business Overview
- 12.9.3 Intel Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.9.4 Intel AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.9.5 Intel Recent Developments
- 12.10 Enlitic
- 12.10.1 Enlitic Company Information
- 12.10.2 Enlitic Business Overview
- 12.10.3 Enlitic Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.10.4 Enlitic AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.10.5 Enlitic Recent Developments
- 12.11 NVIDIA
- 12.11.1 NVIDIA Company Information
- 12.11.2 NVIDIA Business Overview
- 12.11.3 NVIDIA Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.11.4 NVIDIA AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.11.5 NVIDIA Recent Developments
- 12.12 Qure AI
- 12.12.1 Qure AI Company Information
- 12.12.2 Qure AI Business Overview
- 12.12.3 Qure AI Revenue in AI for Clinical and Molecular Diagnostics Business (2021-2026)
- 12.12.4 Qure AI AI for Clinical and Molecular Diagnostics Product Portfolio
- 12.12.5 Qure AI Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst